Latest Articlesddd
Regeneron Pharmaceuticals and Mammoth Biosciences in the NEWS Regeneron Pharmaceuticals (REGN) and Mammoth Biosciences, Inc. announced a …
Immunity Bio in the NEWS Immunity Bio (IBRX) - an immunotherapy company, announced that the U.S. …
Cerevel Therapeutics in the NEWS Cerevel Therapeutics (CERE) announced positive topline results from its pivotal Phase …
Vertex Pharmaceuticals in the NEWS Vertex Pharmaceuticals (VRTX) announced advancements across its suzetrigine pain program, which …
Voyager Therapeutics Voyager Therapeutics (VYGR) is a biotech company dedicated to leveraging the power of human …
Vertex Pharmaceuticals Acquisition of Alpine Immune Sciences We start this posting by answering a question by …
Syndax Pharmaceuticals in the NEWS Yesterday, Syndax Pharmaceuticals (NASDAQ: SNDX) announced the presentation of positive data …
Madrigal Pharmaceuticals in the NEWS Today, April 09, 2024, Madrigal Pharmaceuticals (MDGL) announced that its NASH …
Johnson & Johnson in the NEWS Today, Apr. 5, 2024 - Johnson & Johnson (JNJ) and …
BioStem Technologies Inc From Jason Matuszewski, CEO of BioStem Technologies (BSEM), who stated, “BioStem had an …
BioStem Technologies to Release Fourth Quarter Results BioStem Technologies (BSEM) is hosting a conference call and …
We are currently working to bring into the upcoming ProhostBiotech Letter some small clinical and commercial …
AbbiVie Inc's Acquisition and Approval 1. AbbVie's Acquisition AbbVie Inc. (ABBV) and Landos Biopharma, Inc. …
Novo Nordisk in the NEWS Novo Nordisk (NVO) and Cardior Pharmaceuticals announced that Novo Nordisk agreed …
Italfarmaco in the NEWS From Milan, Italy: Today, Italfarmaco announced that the U.S. Food and Drug …
Illumina in the NEWS On March 21, 2024, we learned that the EU antitrust regulators suffered …
During a discussion with colleagues about the best way to select small and new biotechnology firms …
Madrigal Pharmaceuticals in the NEWS Yesterday, March 14, 2024 Madrigal Pharmaceuticals (MDGL) announced that the U.S. …
The Market Today the Stock Market is bearish and most of the biotech stocks are down …
Arcturus Therapeutics Fourth Quarter and Full Year 2023 Earnings Conference Call Before listening to the Conference …
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it. Accept Privacy policy
